AMP biosynthetic process

pathway activity — cross-omics
GO:0006167Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the AMP biosynthetic process pathway is significantly associated with the RNA expression of multiple genes, with the PDAC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are ADSS1, LRRN4, and SLC34A2, each associated with the pathway in up to 6 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, AMP biosynthetic process activity versus ADSS1 in PDAC (Pearson r = 0.33).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
PDACADSS1 →+0.669+0.160<.001<.00136
LUADLRRN4 →-1.047-0.118.002.00234
CCRCCSLC34A2 →-2.323-0.182<.001.00134
GBMPTPN3 →-0.732-0.080.005.00634
OVSLC6A20 →-0.892-0.160.006.00134
BRCACLEC10A →+0.839+0.093<.001.00234
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0006167 vs ADSS1 — PDAC

Per-sample scatter of AMP biosynthetic process activity vs ADSS1 in PDAC.

Explore this scatter interactively →

Exploration